AtaiBeckley ATAI
NASDAQ ATAI
$7.39 +0.05 (+0.68%)
As of: Sep 4, 2026 · 3:59 PM EDT

AtaiBeckley (ATAI) Operating Leases (2022 - 2026)

AtaiBeckley (ATAI) posted quarterly Operating Leases of $1.7 million for Q1 2026, down 6.16% quarter-over-quarter from $1.8 million in Q4 2025.

Analysis

AtaiBeckley (ATAI) Operating Leases (2022 - 2026) Analysis & Trends

AtaiBeckley's Operating Leases history runs 3 years deep, the most recent figure standing at $1.7 million for Q1 2026.

  • In Q1 2026, Operating Leases changed N/A year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (changed N/A YoY), while the FY2025 annual figure was $1.8 million, up 146.04% from the prior year.
  • Operating Leases for Q1 2026 stood at $1.7 million, down from $1.8 million in the prior quarter.
  • Over five years, Operating Leases peaked at $2.6 million in Q2 2025 and troughed at $44000.0 in Q4 2022.
  • A 4-year average of $1.3 million and a median of $1.0 million in 2023 frame the typical range for Operating Leases.
  • Peak annual rise in Operating Leases reached 146.04% in 2025, while the deepest fall reached 146.04% in 2025.
  • AtaiBeckley's Operating Leases stood at $732000.0 in 2024, then surged by 146.04% to $1.8 million in 2025, then retreated by 6.16% to $1.7 million in 2026.
  • Business Quant data shows ATAI's Operating Leases at $1.7 million in Q1 2026, $1.8 million in Q4 2025, and $732000.0 in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 AtaiBeckley 1.61 Bn 1.61 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.57 Mn
Mar 31, 2026 1.69 Mn
Dec 31, 2025 1.80 Mn
Sep 30, 2025 2.43 Mn
Jun 30, 2025 2.62 Mn
Mar 31, 2025 2.59 Mn
Dec 31, 2024 732,000.00
Dec 31, 2024 732,000.00
Sep 30, 2024 1.07 Mn
Jun 30, 2024 1.08 Mn
Mar 31, 2024 907,000.00
Dec 31, 2023 990,000.00
Sep 30, 2023 1.01 Mn
Jun 30, 2023 1.10 Mn
Mar 31, 2023 1.19 Mn
Dec 31, 2022 44,000.00